Increased risk of antipsychotic-related QT prolongation during nighttime: A 24-hour holter electrocardiogram recording study

Journal of Clinical Psychopharmacology

Volumn 32, Issue 1, 2012, Pages 18-22

  Watanabe, Junzo ^a   Suzuki, Yutaro ^a   Fukui, Naoki ^a   Ono, Shin ^a   Sugai, Takuro ^a   Tsuneyama, Nobuto ^a   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

24 hour Holter ECG recording; drug related long QT syndrome; olanzapine; risperidone; schizophrenia

Indexed keywords

OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CIRCADIAN RHYTHM; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIGNAL PROCESSING, COMPUTER-ASSISTED; TORSADES DE POINTES;

EID: 84855350098     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31823f6f21     Document Type: Article

References (34)

1. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225-235.
2. Hennessy S, Bilker WB, Knauss JS, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ. 2002;325:1070.
3. Yerrabolu M, Prabhudesai S, Tawam M, et al. Effect of risperidone on QT interval and QT dispersion in the elderly. Heart Dis. 2000;2:10-12.
4. Cohen H, Loewenthal U, Matar M, et al. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry. 2001;179:167-171.
5. Agelink MW, Majewski T, Wurthmann C, et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol. 2001;21:8-13. (Pubitemid 32096744)
6. Tran PV, Hamilton SH, Kuntz AJ, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol. 1997;17:407-418. (Pubitemid 27414397)
7. Conley RR, Mahmoud R. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2001;158:765-774. (Pubitemid 32429846)
8. Harrigan EP, Miceli JJ, Anziano R, et al. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol. 2004;24:62-69. (Pubitemid 38134167)
9. Browne KF, Prystowsky E, Heger JJ, et al. Prolongation of the Q-T interval in man during sleep. Am J Cardiol. 1983;52:55-59. (Pubitemid 13061326)
10. Azie NE, Adams G, Darpo B, et al. Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies. Ann Noninvasive Electrocardiol. 2004;9:166-174. (Pubitemid 38594724)
11. Chung MK, Schweikert RA, Wilkoff BL, et al. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications. J Am Coll Cardiol. 1998;32:169-176.
12. Okada Y, Ogawa S, Sadanaga T, et al. Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography. J Am Coll Cardiol. 1996;27: 84-89. (Pubitemid 26018921)
13. Smetana P, Pueyo E, Hnatkova K, et al. Effect of amiodarone on the descending limb of the Twave. Am J Cardiol. 2003;92:742-746. (Pubitemid 37103037)
14. Extramiana F, Maison-Blanche P, Cabanis MJ, et al. Clinical assessment of drug-induced QT prolongation in association with heart rate changes. Clin Pharmacol Ther. 2005;77:247-258. (Pubitemid 40470381)
15. Noel GJ, Goodman DB, Chien S, et al. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings. J Clin Pharmacol. 2004;44:464-473. (Pubitemid 38509714)
16. Ohnishi K, Yoshida H, Shigeno K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med. 2000;133:881-885.
17. Ramirez-Mayans J, Garrido-Garcia LM, Huerta-Tecanhuey A, et al. Cisapride and QTc interval in children. Pediatrics. 2000;106: 1028-1030.
18. Sugao M, Fujiki A, Sakabe M, et al. New quantitative methods for evaluation of dynamic changes in QT interval on 24 hour Holter ECG recordings: QT interval in idiopathic ventricular fibrillation and long QT syndrome. Heart. 2006;92:201-207. (Pubitemid 43131962)
19. Bazett JC. An analysis of time relations of electrocardiograms. Heart. 1920;7:353-367.
20. Karjalainen J, Viitasalo M, Manttari M, et al. Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values. J Am Coll Cardiol. 1994;23:1547-1553. (Pubitemid 24182117)
21. Puddu PE, Jouve R, Mariotti S, et al. Evaluation of 10 QT prediction formulas in 881 middle-aged men from the seven countries study: emphasis on the cubic root Fridericia's equation. J Electrocardiol. 1988;21:219-229.
22. Sagie A, Larson MG, Goldberg RJ, et al. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992;70:797-801.
23. Fridericia LS. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand. 1920;53:469-486.
24. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol. 2006;17:333-336. (Pubitemid 43344951)
25. Savopoulos C, Ziakas A, Hatzitolios A, et al. Circadian rhythm in sudden cardiac death: a retrospective study of 2,665 cases. Angiology. 2006;57:197-204. (Pubitemid 44438572)
26. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95. (Pubitemid 32050441)
27. Roden DM. Long QT syndrome: reduced repolarization reserve and the genetic link. J Intern Med. 2006;259:59-69.
28. Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res. 2000;47:219-233. (Pubitemid 30625285)
29. Sanguinetti MC, Jiang C, Curran ME, et al. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299-307.
30. Kongsamut S, Kang J, Chen XL, et al. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. Eur J Pharmacol. 2002;450:37-41.
31. Titier K, Canal M, Deridet E, et al. Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol Appl Pharmacol. 2004;199:52-60. (Pubitemid 39099455)
32. Gluais P, Bastide M, Caron J, et al. Risperidone prolongs cardiac action potential through reduction of K+ currents in rabbit myocytes. Eur J Pharmacol. 2002;444:123-132. (Pubitemid 34626829)
33. Smetana P, Batchvarov VN, Hnatkova K, et al. Sex differences in repolarization homogeneity and its circadian pattern. Am J Physiol Heart Circ Physiol. 2002;282:H1889-H1897. (Pubitemid 34654860)
34. Sredniawa B, Musialik-Lydka A, Jarski P, et al. Circadian and sex-dependent QT dynamics. Pacing Clin Electrophysiol. 2005;28(suppl 1):S211-S216. (Pubitemid 40171118)